Asensus Surgical, Inc.
$235.9K 294 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Fuse Medical, Inc.
Fuse Medical, Inc. reported $236,228.13 across General Payments, Research, and Ownership to 71 physicians and teaching hospitals across 71 transactions.
- $236.2K Above-median payer
- All-tracks total
- 71 Below-median volume
- Transactions
- 71 Below-median reach
- Recipients
- −$155.8K
- General Payments vs PY2023
Fuse Medical, Inc. reported $236,228.13 across all CMS Open Payments tracks (General + Research + Ownership) to 71 physicians and teaching hospitals in Program Year 2024 - ranking #957 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $236,228.13, averaging $3.3K per recipient.
Fuse Medical, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
18/100
Total payments
F
12/100
Transaction volume
F
10/100
Physician reach
F
11/100
Payment type diversity
F
37/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer fuse-medical-inc Fuse Medical, Inc.
$236.2K · #957/1,925 · 0.0% industry · PY2024
- TOT $236.2K
- RANK #957
- SHARE 0.0%
- TXN 71
- RCP 71
- CAT 3
- GEN $236.2K
- ΔGEN −$155.8K
- TOP1 16.9%
- PY 2024
Volume peers
Nearest volume peer: Asensus Surgical, Inc. ($235.9K)
Fuse Medical, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Fuse Medical, Inc.'s CMS-reported General Payments decreased by $155.8K (−39.7%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: FUSE MEDICAL, INC.PY2023: FUSE MEDICAL, INC.PY2024: Fuse Medical, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $392,067.37
- PY2024
- $236,228.13
What the Data Shows for Fuse Medical, Inc.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Fuse Medical, Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
The 3-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Royalty or License" at $121.2K, accounting for 51.3% of this company's General Payments and 45 transactions.
General Payment Breakdown by Type
Across 3 types of general payments, Fuse Medical, Inc.'s largest category was "Royalty or License" at $121.2K - 51.3% of General Payments.
How Fuse Medical, Inc. divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Royalty or License | $121.2K | 45 | 51.3% |
| Consulting Fee | $111.0K | 25 | 47.0% |
| Charitable Contribution | $4.0K | 1 | 1.7% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $166,179.55 (70.3%) of $236,228.13 in this company's General Payments records across 19 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Fuse Medical, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Richard Adams
$40,000.00 across 3 reported transactions
- 2
Dharmesh Bhakta
$40,000.00 across 3 reported transactions
- 3
Kendall Carll II
$37,500.00 across 3 reported transactions
- 4
Jesus Rey II
$25,000.00 across 5 reported transactions
- 5
Robert M Weinstein
$23,679.55 across 5 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Fuse Medical, Inc.'s spend rank (#957 of 1,925, top 50% by spend) and concentration rank (#957 of 1,838, bottom 48% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Medtec LLC : $1.5K total payments, HHI 1192
- Novastep Inc. : $391.6K total payments, HHI 1187
- Amylyx Pharmaceuticals, Inc. : $70.8K total payments, HHI 1184
- Zavation Medical Products, LLC : $696.6K total payments, HHI 1183
- Topcon Healthcare, Inc. : $675.4K total payments, HHI 1183
- MicroPort Orthopedics Inc : $2.8M total payments, HHI 1182
- Fuse Medical, Inc. (this company) : $236.2K total payments, HHI 1179
- Valneva Usa, Inc. : $43.5K total payments, HHI 1173
- Bracco Diagnostics Inc. : $410.3K total payments, HHI 1171
- Instylla, Inc. : $144.2K total payments, HHI 1169
- Reprise Biomedical, Inc. : $117.0K total payments, HHI 1168
- DentalEZ Alabama, Inc. : $5.9K total payments, HHI 1168
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Fuse Medical, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Fuse Medical, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Fuse Medical, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Synthes USA Products LLC
$235.8K 209 recipients
Compare payment profiles
Stability Biologics, LLC
$235.6K 106 recipients
Compare payment profiles
MiRus, LLC
$236.9K 126 recipients
Compare payment profiles
I/O Urology Corp.
$234.3K 22 recipients
Compare payment profiles
ABB Con-Cise Optical Group LLC
$238.5K 1,083 recipients
Compare payment profiles
Put this to use
Fuse Medical, Inc. ranks #957 of 1,925 by all-tracks total payments, led by "Royalty or License".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Royalty or License" spend across every manufacturer, not just Fuse Medical, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.